Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Francisco Valenzuela-Sánchez"'
Autor:
Francisco Valenzuela-Sánchez, Blanca Valenzuela-Méndez, Juan Francisco Rodríguez-Gutiérrez, Ángel Estella
Publikováno v:
Journal of Intensive Medicine, Vol 4, Iss 2, Pp 160-174 (2024)
Influenza pandemics are unpredictable recurrent events with global health, economic, and social consequences. The objective of this review is to provide an update on the latest developments in early diagnosis and specific treatment of the disease and
Externí odkaz:
https://doaj.org/article/330e307de9a14b608738d08ccd541bb8
Autor:
Blanca Valenzuela-Méndez, Francisco Valenzuela-Sánchez, Juan Francisco Rodríguez-Gutiérrez, Rafael Bohollo-de-Austria, Ángel Estella, Pilar Martínez-García, María Ángela González-García, Grant Waterer, Jordi Rello
Publikováno v:
European journal of internal medicine. 104
Limited knowledge exists on how early host response impacts outcomes in influenza pneumonia.This study assessed what was the contribution of host immune response at the emergency department on hospital mortality amongst adults with influenza A H1N1pd
Autor:
Laura Campogiani, Elena Xu, Jordi Rello, Candela Solé-Lleonart, Despoina Koulenti, Francisco Valenzuela-Sánchez, Sofia Tejada
Publikováno v:
Clinical Nutrition ESPEN. 39:144-149
Aims: The primary aim of this study was to evaluate the quality of evidence supporting the 2019 European Society for Clinical Nutrition and Metabolism (ESPEN) and 2016 American Society for Parenteral and Enteral Nutrition (ASPEN) recommendations for
Publikováno v:
EPISTEMUS. 13:42-47
Las tecnologías de microarreglos abren un gran abanico de posibilidades a la investigación a nivel molecular. Esta técnica comenzó a mediados de los 90 con los estudios de Schena y Lockhart quienes describieron por primera vez el desarrollo de un
Autor:
Jordi Rello, Francisco Valenzuela-Sánchez, Blanca Valenzuela-Méndez, J. F. Rodríguez-Gutiérrez
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
Existing therapies against infectious diseases may only be effective in limited subpopulations during specific phases of diseases, incorporating theranostics, and there is a clear need to individualize different therapeutic approaches depending on th
Autor:
María Ángela González-García, J. F. Rodríguez-Gutiérrez, Jordi Rello, Francisco Valenzuela-Sánchez, Rafael Bohollo de Austria, Laura Fernández-Ruiz, Blanca Valenzuela-Méndez, Ángel Estella-García
Publikováno v:
Minerva anestesiologica. 85(4)
BACKGROUND Identifying Intensive Care Unit (ICU) patients with sepsis and predicting the risk of death are unmet clinical needs. METHODS Prospective observational single-center study of 120 consecutive ICU patients with suspected severe sepsis at Jer
Publikováno v:
Advances in Therapy
Infections represent a common health problem in people of all ages. Usually, the response given to them is appropriate and so little treatment is needed. Sometimes, however, the response to the infection is inadequate and may lead to organ dysfunctio
Autor:
J. F. Rodríguez-Gutiérrez, Ángel Estella-García, Blanca Valenzuela-Méndez, María Ángela González-García, Francisco Valenzuela-Sánchez
Mid-regional pro-adrenomedullin (MR-proADM) has a good biomarker profile: its half-life is several hours, and its plasma concentrations can be determined in clinical practice, it is essentially irrelevant, but proportionally represents the levels and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39edef479c62039e7219688184e5f82
https://europepmc.org/articles/PMC5050192/
https://europepmc.org/articles/PMC5050192/
Publikováno v:
Journal of thoracic disease. 8(6)
Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. Patients with septic shock can be identified with a clinical construct of sepsis with per
Publikováno v:
Epistemus, Vol 13, Iss 27 (2020)
Las tecnologías de microarreglos abren un gran abanico de posibilidades a la investigación a nivel molecular. Esta técnica comenzó a mediados de los 90 con los estudios de Schena y Lockhart quienes describieron por primera vez el desarrollo de un
Externí odkaz:
https://doaj.org/article/d195ea3381d44d2f9ce1670f6b5e2edf